IMMUNOTHERAPY WITH COMBINATION THERAPY COMPRISING AN IMMUNOTOXIN
US Application 19/410,830
Filed on 2025-12-05
Filed on 2025-12-05
METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF
Cyprus
15746399.3
Filed on 2015-02-04
15746399.3
Filed on 2015-02-04
IDENTIFICATION OF SEQUENCE VARIANTS OF THE ERVMER34-1 SEQUENCE
FAMILY AND USE IN ANTI-CANCER THERAPIES
US Application 19/502,979
Filed on 2026-01-16
Filed on 2026-01-16
IDENTIFICATION OF SEQUENCE VARIANTS OF THE ERVMER34-1 SEQUENCE FAMILY AND USE IN ANTI-CANCER THERAPIES
Australia
2024296108
Filed on 2026-02-09
2024296108
Filed on 2026-02-09
IDENTIFICATION OF SEQUENCE VARIANTS OF THE ERVMER34-1 SEQUENCE FAMILY AND USE IN ANTI-CANCER THERAPIES
Canada
3298848
Filed on 2026-01-15
3298848
Filed on 2026-01-15
KINASE INHIBITORS
US Application 19/502,510
Filed on 2026-01-15
Filed on 2026-01-15
HUMANIZED 40H3 ANTIBODY
European Patent
24748511.3
Filed on 2026-01-27
24748511.3
Filed on 2026-01-27
HUMANIZED 40H3 ANTIBODY
US Application 19/497,173
Filed on 2025-12-24
Filed on 2025-12-24
HUMANIZED 40H3 ANTIBODY
Australia
2024296940
Filed on 2026-01-13
2024296940
Filed on 2026-01-13
HUMANIZED 40H3 ANTIBODY
Canada
3297257
Filed on 2025-12-30
3297257
Filed on 2025-12-30